In contrast, CSF p‐tau235 had a similar accuracy to CSF p‐tau217 and p‐tau231 distinguishing CI− and CI+, which indicates that once cognitive impairment is clinically established, all p‐tau assays perform similarly identifying AD pathology. Here, MAPT is linked to Alzheimer disease.